Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-807-1 | CAS number: 542-28-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Oral: The acute oral LD50 was determined to be > 2000 mg/kg bw in rats.
Dermal: The acute dermal LD50 was determined to be > 5000 mg/kg bw in rats.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989-11-14 to 1989-11-29
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Study similar to guideline but without GLP
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: DR. K. THOMAE GMBH, D-7950 BIBERACH, FRG
- Age at study initiation: young adult animals
- Weight at study initiation: 172 g for males and females
- Fasting period before study: about 16 h before administration
- Housing: stainless steel wire mesh cages, type DK-III (BECKER & CO., CASTROP-RAUXEL, FRG )
- Diet (e.g. ad libitum): ad libitum (KLIBA-LABORDIAET 343, KLINGENTALMUEHLE AG CH-4303 KAISERAUGST, SWITZERLAND)
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least one week
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30-70
- Photoperiod (hrs dark / hrs light): 12 H/12 H (6.00 - 18.00 HOURS/ 18.00 - 6.00 HOURS) - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Administration volume: 10 mL/kg
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: recording of signs and symptoms several times on the day of administration. At least once each work day. Check for moribund and dead animals twice each workday and once on holidays. Weighing on days 7 and 13.
- Necropsy of survivors performed: yes - Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality noted.
- Clinical signs:
- other: No clinical signs noted.
- Gross pathology:
- No pathologic findings noted.
- Other findings:
- None
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Similar to guideline study, whole database factor: 1.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline Study OECD 402 with GLP compliance
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Wiga GmbH, Sandhofer Weg 7, 97633 Sulzfeld, Germany
- Age at study initiation: male animals approx. 8 weeks, female animals approx. 12 weeks
- Weight at study initiation: 200-250 g
- Fasting period before study: No
- Housing: single
- Diet: VRF1(P); SDS Special Diets Services, 67122 Altrip, Germany
- Water: Tap water, ad libitum
- Acclimation period: Acclimatization period of at least 5 days before the beginning of the experimental phase; during the acclimatization period, the animals were accustomed to the environmental conditions of the study and to the diet.
ENVIRONMENTAL CONDITIONS
- Temperature: 22°C ± 3°C
- Humiddity: 30 – 70%
- Photoperiod (hrs dark / hrs light): 12 h / 12 h (6.00 a.m. – 6.00 p.m. / 6.00 p.m. – 6.00 a.m.)
IN-LIFE DATES: From: 2012-01-23 To: 2012-02-15 - Type of coverage:
- semiocclusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: dorsal and dorso-lateral parts of the trunk
- % coverage: 10 % of the total body surface area
- Type of wrap if used: air-permeable dressing (4 layers of absorbent gauze and stretch bandage)
REMOVAL OF TEST SUBSTANCE
- Washing: rinsing of the application site with warm water
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied: 4.5 mL/kg bw
- Concentration: undiluted
- Constant volume or concentration used: constant concentration
VEHICLE
- unchanged (no vehicle) - Duration of exposure:
- 24 h
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Recording of clinical signs several times on the day of administration, and at least once daily thereafter
each workday for the individual animals. Individual body weights shortly before administration (day 0), weekly thereafter and on the last day of
observation
- Necropsy of survivors performed: yes, incl. gross-pathology examination
- Other examinations performed: scoring of skin findings 30 – 60 minutes after removal of the semi-occlusive dressing (day 1), weekly thereafter and
on the last day of observation, mortality or moribund animals at least once each workday. - Statistics:
- Not performed.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality was observed.
- Clinical signs:
- other: No signs of systemic toxicity or skin effects were observed in the animals. No local findings were observed.
- Gross pathology:
- No macroscopic pathologic abnormalities were noted in the animals examined at the end of the study.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- GLP and guideline study, whole database factor: 1.
Additional information
Oral:
In an acute oral toxicity study (BASF SE, 1989), a group of young adult 5 male and female , fasted Wistar rats were given a single oral dose of Delta-Valerolactone in water at a dose of 2000 mg/kg bw (limit test) and observed for 14 days. No clinical signs, mortality or necropsy findings were noted and no influence on body weight was reported.
Oral LD50Males = > 2000 mg/kg bw
Females = > 2000 mg/kg bw
Combined = > 2000 mg/kg bw
Delta-Valerolactone is of NO NOTICEABLE toxicity based on the LD50in male and female rats.
Inhalation (waiver):
In accordance with column 2 of REACH Annex VIII, the test acute toxicity after inhalation (required in section 8.5) does not need to be conducted as acute toxicity studies for oral and dermal application are available.
Dermal:
In an acute dermal toxicity study (Bioassay, 2012), a group of young adult 5 male and female Wistar rats were dermally exposed to Delta-Valerolactone (100% purity) for 24 hours to 10% of body surface area at a dose of 5000 mg/kg bw (limit test). Animals then were observed for 14 days. There were no treatment related clinical signs, mortality, necropsy findings or changes in body weight.
Dermal LD50Males = > 5000 mg/kg bw
Females = > 5000 mg/kg bw
Combined = > 5000 mg/kg bw
Delta-Valerolactone is of NO NOTICEABLE toxicity based on the LD50 values in male and female rats.
Justification for selection of acute toxicity – oral endpoint
The key study was selected for selection.
Justification for selection of acute toxicity – dermal endpoint
The key study was selected for selection.
Justification for classification or non-classification
Classification for acute toxicity is not warranted according to the criteria of EU Directive 67/548/EEC and EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)